Oct 7, 2026 06:50AM
Oct 6, 2026 07:00AM
Oct 6, 2026 07:00AM
Sep 9, 2026 07:00AM
Sep 8, 2026 07:00AM
Jul 20, 2026 07:00AM
Jul 20, 2026 07:00AM OKYO Pharma Announces Filing of Annual Report with Strengthened Cash Position and Accelerated Phase 3 Plans
Jul 13, 2026 06:40AM
Jul 8, 2026 07:00AM
Jul 8, 2026 07:00AM
May 19, 2026 07:00AM
May 19, 2026 07:00AM
Apr 29, 2026 07:00AM
Apr 7, 2026 09:43AM OKYO Pharma to present urcosimod data at ophthalmology conference
Apr 7, 2026 07:00AM
Apr 7, 2026 07:00AM
Apr 7, 2026 07:00AM
Mar 18, 2026 07:00AM
Mar 18, 2026 07:00AM
Feb 23, 2026 11:00AM
Feb 10, 2026 08:00AM OKYO Pharma names Flavio Mantelli as chief medical officer
Feb 10, 2026 08:00AM
Jan 30, 2026 11:30AM
Jan 30, 2026 11:30AM
Jan 29, 2026 06:52AM
Jan 28, 2026 07:40AM
Jan 28, 2026 07:40AM
Jan 26, 2026 06:50AM H.C. Wainwright Reiterates Buy Rating on OKYO Pharma Ltd. (OKYO)
Jan 23, 2026 07:00AM
Jan 23, 2026 07:00AM
Jan 5, 2026 07:00AM
Jan 5, 2026 07:00AM
Dec 19, 2025 07:00AM
Dec 15, 2025 08:33AM
Dec 15, 2025 08:30AM OKYO Pharma Announces Chairman and Founder Acquires Shares
Dec 11, 2025 08:30AM
Dec 11, 2025 08:30AM
Dec 7, 2025 11:48PM
Dec 3, 2025 07:01AM
Dec 3, 2025 07:00AM
Nov 21, 2025 08:30AM
Nov 21, 2025 08:30AM OKYO Pharma Announces Chairman and Founder Acquires Shares
Nov 18, 2025 08:30AM
Oct 29, 2025 07:00AM
Oct 16, 2025 08:30AM
Oct 16, 2025 08:30AM
Sep 23, 2025 06:39AM
Sep 22, 2025 08:35AM
Sep 22, 2025 08:30AM OKYO Pharma Announces Registration Pathway with 100 Patient Multi-Center Clinical Trial of Urcosimod in Neuropathic Corneal Pain
Jul 17, 2025 09:00AM

334,274 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All